Who owns ANI PHARMACEUTICALS INC?
- CUSIP Number: 00182cac7
Tip: Access positions for across all investors
Analyze quarterly positions in Ani Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ani Pharmaceuticals stock
Who bought or sold ANI PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Point72 Asset Management | 48M | $62M | 219% | Jun 2026 |
|
| Citadel Advisors | 35M | $45M | 40% | Jun 2026 |
|
| Camden Asset Management | 34M | $44M | -16% | Jun 2026 |
|
| Alberta Investment Management Corporation | 30M | $39M | 0% | Jun 2026 |
|
| Empyrean Capital Partners | 23M | $30M | -2% | Jun 2026 |
|
| HBK Investments | 20M | $26M | 0% | Jun 2026 |
|
| BlackRock | 15M | $20M | 19% | Jun 2026 |
|
| Absolute Investment Advisers | 12M | $15M | 2% | Jun 2026 |
|
| Readystate Asset Management | 9.5M | $12M | -34% | Jun 2026 |
|
| Jpmorgan Chase & Co | 9.3M | $12M | 100% | Jun 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 8.3M | $11M | 4% | Jun 2026 |
|
| Goldman Sachs Group | 7.0M | $9.0M | 40% | Jun 2026 |
|
| Nykredit A/S | 6.0M | $7.8M | 100% | Jun 2026 |
|
| Gabelli Funds | 5.1M | $6.6M | 0% | Jun 2026 |
|
| FMR | 2.5M | $3.3M | -1% | Jun 2026 |
|
| Citigroup | 1.5M | $1.9M | 100% | Mar 2026 |
|
| Jane Street | 865k | $1.1M | 128% | Jun 2026 |
|
| Barclays | 719k | $935k | 100% | Jun 2026 |
|
| Bank of New York Mellon | 650k | $845k | -35% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 649k | $844k | 0% | Jun 2026 |
|
| Lazard Asset Management | 351k | $4.6k | 0% | Jun 2026 |
|
| Morgan Stanley | 337k | $417k | -60% | Mar 2026 |
|
| Wellesley Investment Advisors | 250k | $325M | 100% | Jun 2026 |
|
| Ares Systematic Credit | 100k | $130k | 100% | Jun 2026 |
|
| Boussard & Gavaudan Investment Management | 13k | $17M | -28% | Mar 2026 |
|
| Alken Asset Management | 1.4k | $1.8M | 8% | Jun 2026 |
|
Who sold out of Ani Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Balyasny Asset Management | Mar 2026 | 15M | $19M |
| Aristeia Capital | Mar 2026 | 8.0M | $9.9M |
| Leucadia National Corporation | Mar 2026 | 5.1M | $6.3M |
| Jump Financial | Mar 2026 | 3.5M | $4.3M |